BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29684755)

  • 1. Impaired TGF-β signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22.
    Rekik R; Smiti Khanfir M; Larbi T; Zamali I; Beldi-Ferchiou A; Kammoun O; Marzouki S; Hamzaoui S; Mrad S; Barbouche MR; Houman MH; Ben Ahmed M
    Cytokine; 2018 Aug; 108():182-189. PubMed ID: 29684755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to exogenous TGF-β effects in patients with systemic lupus erythematosus.
    Elbeldi-Ferchiou A; Ben Ahmed M; Smiti-Khanfir M; Houman MH; Abdeladhim M; Belhadj Hmida N; Cerf-Bensussan N; Louzir H
    J Clin Immunol; 2011 Aug; 31(4):574-83. PubMed ID: 21503670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
    Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
    Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
    Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TGFbeta1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus.
    Kohut E; Hajdu M; Gergely P; Gopcsa L; Kilián K; Pálóczi K; Kopper L; Sebestyén A
    Pathol Oncol Res; 2009 Jun; 15(2):251-6. PubMed ID: 19020994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of umbilical cord mesenchymal stem cells in the up-regulation of regulatory T cells by transforming growth factor β1 in systemic lupus erythematosus].
    Lu L; Wang DD; Li X; Zeng XF; Sun LY
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):980-3. PubMed ID: 23886259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
    Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity.
    Ohtsuka K; Gray JD; Stimmler MM; Horwitz DA
    Lupus; 1999; 8(2):90-4. PubMed ID: 10192501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.
    Manolova I; Gerenova J; Ivanova M
    Eur Cytokine Netw; 2013 Mar; 24(1):69-74. PubMed ID: 23614931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus.
    Yuan Y; Yang M; Wang K; Sun J; Song L; Diao X; Jiang Z; Cheng G; Wang X
    Arthritis Res Ther; 2017 Mar; 19(1):70. PubMed ID: 28356164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
    Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
    Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
    McKarns SC; Schwartz RH; Kaminski NE
    J Immunol; 2004 Apr; 172(7):4275-84. PubMed ID: 15034041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus.
    Lu LY; Cheng HH; Sung PK; Yeh JJ; Shiue YL; Chen A
    J Microbiol Immunol Infect; 2004 Jun; 37(3):145-52. PubMed ID: 15221033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q; Su H; Cui J; Wang B
    Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
    Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
    Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
    Guo Q; Chen XY; Su Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM; Urra JM; Carreño A; Zamorano J
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.